TFF Pharmaceuticals(TFFP) - 2022 Q2 - Earnings Call Transcript

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO & Director Kirk Coleman - Chief Financial Officer Dale Christensen - Director of Clinical Development Chris Cano - Chief Operating Officer. Bill Williams - University of Texas at Austin Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Daniel Carlson - TW Research Group Michael Okunewitch - Maxim Group Operat ...